Teleflex Incorporated $TFX Shares Acquired by Diamond Hill Capital Management Inc.

Diamond Hill Capital Management Inc. lifted its stake in shares of Teleflex Incorporated (NYSE:TFX) by 6.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 349,809 shares of the medical technology company’s stock after buying an additional 20,773 shares during the quarter. Diamond Hill Capital Management Inc.’s holdings in Teleflex were worth $42,691,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Ruffer LLP acquired a new position in shares of Teleflex during the fourth quarter worth about $5,154,000. Waterfront Wealth Inc. acquired a new position in shares of Teleflex during the fourth quarter worth about $2,050,000. Eos Management L.P. acquired a new position in shares of Teleflex during the fourth quarter worth about $3,763,000. Capital International Investors acquired a new position in shares of Teleflex during the third quarter worth about $44,851,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH boosted its holdings in Teleflex by 227.5% in the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 27,822 shares of the medical technology company’s stock valued at $3,395,000 after purchasing an additional 19,327 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Price Performance

Shares of NYSE TFX opened at $131.77 on Friday. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $139.67. The stock has a 50 day moving average of $122.22 and a two-hundred day moving average of $116.82. The stock has a market cap of $5.83 billion, a P/E ratio of -5.78, a P/E/G ratio of 1.01 and a beta of 0.82.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. During the same quarter in the previous year, the business earned $1.44 earnings per share. The firm’s revenue for the quarter was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, research analysts forecast that Teleflex Incorporated will post 6.7 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be paid a $0.34 dividend. The ex-dividend date is Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s payout ratio is currently -5.96%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on TFX shares. Truist Financial reaffirmed a “hold” rating and issued a $143.00 price target (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and upped their price target for the company from $135.00 to $155.00 in a report on Friday, May 8th. Bank of America raised Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target for the company in a report on Monday, April 13th. Mizuho set a $140.00 price target on Teleflex in a report on Friday, May 8th. Finally, Wall Street Zen downgraded Teleflex from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Three equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $144.00.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.